Novel equation to determine the hepatic triglyceride concentration in humans by MRI: Diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Jiménez Agüero, Raúl ^a,b   Emparanza, José I ^b   Beguiristain, Adolfo ^a   Bujanda, Luis ^a,c   Alustiza, José M ^a,d   García, Elisabeth ^d   Hijona, Elizabeth ^a,c   Gallego, Lander ^a   Sánchez González, Javier ^e   Perugorria, María J ^a,c,f   Asensio, José I ^a   Larburu, Santiago ^a   Garmendia, Maddi ^g   Larzabal, Mikel ^g   Portillo, María P ^h   Aguirre, Leixuri ^h   Banales, Jesús M ^a,c,f  

^a HOSPITAL DONOSTIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Osatek SA   (Spain)

^e PHILIPS HEALTHCARE   (United States)

^f BASQUE FOUNDATION FOR SCIENCE   (Spain)

^g Biodonostia Health Research Institute HUD   (Spain)

^h UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bariatric surgery; Diagnosis; Hepatic fat concentration; Magnetic resonance imaging; Non alcoholic fatty liver disease; Obesity

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIPID LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; BARIATRIC SURGERY; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; EVALUATION STUDY; METABOLISM; OBESITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX;

BARIATRIC SURGERY; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 84929942878     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0137-y     Document Type: Article

References (28)

1. Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A, Celik A, Bahar K, Karcaaltincaba M: Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013, 267:767-775.
2. Vernon G, Baranova A, Younossi ZM: Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
3. Adams LA, Lindor KD: Nonalcoholic fatty liver disease. Ann Epidemiol 2007, 17:863-869.
4. Kawamitsu H, Kaji Y, Ohara T, Sugimura K: Feasibility of quantitative intrahepatic lipid imaging applied to the magnetic resonance dual gradient echo sequence. Magn Reson Med Sci 2003, 2:47-50.
5. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, LIDO Study Group: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005, 128:1898-1906.
6. Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, Rybicki L, McCullough AJ: Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998, 11:560-565.
7. Marsman H, Matsushita T, Dierkhising R, Kremers W, Rosen C, Burgart L, Nyberg SL: Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 2004, 35:430-435.
8. Zaitoun AM, Al Mardini H, Awad S, Ukabam S, Makadisi S, Record CO: Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol 2001, 54:461-465.
9. Reeder SB, Cruite I, Hamilton G, Sirlin CB: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011, 34:729-749.
10. Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB: Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013, 267:422-431.
11. *: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T-feasibility. Radiology 2008, 247:550-557.
12. WHO: Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. In WHO Technical Report Series 894. Geneva: World Health Organization; 2000.
13. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
14. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
15. Iverson S, Lang S, Cooper M: Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids 2001, 11:1283-1287.
16. Hijona E, Sanchez-Gonzalez J, Alustiza JM, Hijona L, Arenas J, Garcia E, Rojas N, Portillo MP, Jimenez R, Aldazabal P, Bujanda L: Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease. Eur J Radiol 2012, 81:1122-1127.
17. Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, Jo JY, Yi NJ, Suh KS, Shin KS, Jo SY, Choi BI: Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings. Radiology 2006, 240:116-129.
18. Guiu B, Petit JM, Loffroy R, Ben Salem D, Aho S, Masson D, Hillon P, Krause D, Cercueil JP: Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009, 250:95-102.
19. Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, Hassanein T, Patton HM, Lavine JE, Schwimmer JB, Sirling CB: Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009, 251:67-76.
20. Guiu B, Petit JM, Loffroy R, Aho S, Ben Salem D, Masson D, Robin I, Verges B, Hillon P, Cercueil JP, Krausé D: Liver methylene fraction by dual-and triple-echo gradient-echo imaging at 3.0 T: correlation with proton MR spectroscopy and estimation of robustness after SPIO administration. J Magn Reson Imaging 2011, 33:119-127.
21. Cesbron-Metivier E, Roullier V, Boursier J, Cavaro-Menard C, Lebigot J, Michalak S, Cales P, Aube C: Noninvasive liver steatosis quantification using MRI techniques combined with blood markers. Eur J Gastroenterol Hepatol 2010, 22:973-982.
22. Guaraldi G, Besutti G, Stentarelli C, Zona S, Nocetti L, Loria P, Ballestri S, Losi L, Torricelli P, Ligabue G: Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. Antivir Ther 2012, 17:965-971.
23. Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, Loomba R: Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease -MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012, 36:22-29.
24. Iverson SJ, Lang SL, Cooper MH: Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids 2001, 36:1283-1287.
25. Hines CD, Yu H, Shimakawa A, McKenzie CA, Warner TF, Brittain JH, Reeder SB: Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010, 254:119-128.
26. Korkusuz H, Keese D, Raschidi BA, Hubner F, Namgaladze D, Hintereder G, Hammerstingl R, Korkusuz Y, Monch C, Vogl TJ: Detection of a fatty liver after binge drinking: correlation of MR-spectroscopy, DECT, biochemistry and histology in a rat model. Acad Radiol 2011, 18:1349-1357.
27. Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, Tian Y, Oberkofler CE, Clavien PA: MRI: the new reference standard in quantifying hepatic steatosis? Gut 2012, 61:117-127.
28. Roldan-Valadez E, Favila R, Martinez-Lopez M, Uribe M, Rios C, Mendez-Sanchez N: In vivo 3 T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: correlation with biochemical method and morphometry. J Hepatol 2010, 53:732-737.